As one of the most difficult cancers to treat, childhood brain tumors are the leading cause of cancer-related deaths in children under age 10. However, researchers are making more progress than ever before.
“Over the last 10 years there has been a lot of excitement about new treatments for pediatric brain tumors,” says Peter Manley, MD, a pediatric neuro-oncologist with Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and director of the Stop & Shop Family Pediatric Neuro-Oncology Outcomes Clinic. “We’re looking at brain tumors on a molecular level to find potential targeted therapies that can not only treat the cancer, but also minimize long-term side effects.”
Manley recently joined Mark Kieran, MD, PhD, clinical director of the Pediatric Brain Tumor Center at Dana-Farber/Boston Children’s, for a live webchat on the latest treatments and research for pediatric brain tumors. Manley and Kieran discussed precision medicine, immunotherapy, and radiation therapy, as well as new information about the long-term survival of patients and ways to reduce treatment side effects.
“The treatment of brain tumors is incredibly complex and, perhaps more than any other disease we deal with, takes a team effort to take care of the patient,” says Kieran. “The goal isn’t to have just one person treat a child, it’s about having several people all putting together their expertise to care for the patient.”
Watch the webchat with Manley and Kieran below: